Bringing Clinical Trials to Life, From Lab to Reality

Fields of specialisation

• Immunotherapy, oncology and covering personalised therapy field (Silvija Jarnjak MD, PhD)*
• 20 years of expertise in clinical trials - such as Lung cancer, Head and Neck cancer, Prostate Cancer and other solid tumour, Skin Cancers, Haematological Malignancies, Gynaecological Oncology
• Autoimmune Disease's (IgA nephropathy, Multiple Sclerosis, Systemic Lupus (SLE))
• Female Health (treatment of female sterility, treatment of post-menopausal syndrome)

We look into your challenges from different aspects, and tailor solutions for your company so you can achieve your goals and improve health on a global level.

* Immunotherapy is a relatively new field of cancer treatment that uses the body’s own immune system to fight the cancer. It works by either boosting the body’s natural immune system or introducing new components to the body to help it target and attack cancer cells. Personalised therapy is a type of immunotherapy that is tailored to the individual. It uses genetic information to identify the specific mutations in a person's cancer cells that are driving the tumour’s growth. This helps to target the specific treatment to each individual and potentially improve the chances of success. Personalised therapy is being used in a variety of oncology settings, including for lung cancer, kidney cancer, and melanoma.

About Future Clinical Trials Consulting

Clinical trials are a crucial part of the drug development process and play a vital role in advancing medical research. These trials are designed to test the safety and efficacy of new treatments, devices, or interventions before they can be approved and made available to the public. During a clinical trial, a carefully selected group of volunteers receives the intervention being tested, while another group receives either a placebo or a standard treatment. The results of these trials are carefully monitored and analyzed to determine the safety and effectiveness of the intervention.

Clinical trials follow strict protocols to ensure the safety of participants and the validity of the results. The trials are conducted in phases, starting with small, early-phase trials to evaluate safety and determine appropriate dosing, followed by larger, later-phase trials to assess efficacy and gather additional safety data. The results of clinical trials inform regulatory agencies about the risks and benefits of new treatments and help guide decisions about whether to approve them for use.

The clinical trial traject

Overall, clinical trials play a crucial role in advancing medical research and improving public health. They offer hope to individuals who may have exhausted other treatment options and provide a way for them to contribute to the development of new treatments that could benefit others in the future.

What we do for our partners

How we support our partners

FCTC is helping emerging biotech and Pharma companies meet their milestones to market.

Oversight of CRO and other vendor activities are Key

Yes, clinical trial oversight is essential in ensuring the quality, safety, and efficacy of the trial, and it is the responsibility of the sponsor to ensure that all clinical trial activities are conducted in accordance with regulatory requirements and ethical standards.

Acting as a bridge between Sponsor and Vendor, as a Sponsor Medical Monitor and Medical/ Safety Advisor

Yes, the role of a Sponsor Medical Monitor and Medical/Safety Advisor is to act as a bridge between the sponsor and the vendors (such as CROs) involved in conducting a clinical trial.